MedTrace Logo

International Alfapump Cohort Study

NCT04326946 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 400

Last updated 2024-11-12

No results posted yet for this study

Summary

This Registry is designed to follow patients who have been implanted with an alfapump system, which is a newly marketed product from Sequana Medical AG, a Swiss Medical Device company.

Conditions

  • Liver Cirrhoses
  • Malignant Ascites

Interventions

DEVICE

Alfapump

alfapump implementation

Sponsors & Collaborators

  • Sequana Medical N.V.

    lead INDUSTRY

Principal Investigators

  • Andrea De Gottardi, MD · Insel Gruppe AG, University Hospital Bern

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-08-14
Primary Completion
2028-12-31
Completion
2030-12-31

Countries

  • Germany
  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04326946 on ClinicalTrials.gov